MedPath

WEST VIRGINIA UNIVERSITY

WEST VIRGINIA UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1867-01-01
Employees
101
Market Cap
-
Website
http://www.wvu.edu

Clinical Trials

144

Active:5
Completed:79

Trial Phases

6 Phases

Early Phase 1:4
Phase 1:12
Phase 2:9
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (134 trials with phase data)• Click on a phase to view related trials

Not Applicable
93 (69.4%)
Phase 4
14 (10.4%)
Phase 1
12 (9.0%)
Phase 2
9 (6.7%)
Early Phase 1
4 (3.0%)
Phase 3
2 (1.5%)

Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (MPAL)

Not Applicable
Not yet recruiting
Conditions
CD19 Positive
Mixed Phenotype Acute Leukemia (MPAL)
Interventions
Drug: Subcutaneous Blinatumomab
First Posted Date
2025-10-30
Last Posted Date
2025-10-30
Lead Sponsor
West Virginia University
Target Recruit Count
78
Registration Number
NCT07222579
Locations
🇺🇸

West Virginia University Cancer Institute, Morgantown, West Virginia, United States

Orthodontic Pain Alleviation With Chewing Gum

Not Applicable
Not yet recruiting
Conditions
Orthodontic Appliances
Interventions
Drug: Xylitol Gum
First Posted Date
2025-10-07
Last Posted Date
2025-10-07
Lead Sponsor
West Virginia University
Target Recruit Count
60
Registration Number
NCT07210697
Locations
🇺🇸

West Virginia University, Morgantown, West Virginia, United States

Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?

Not Applicable
Conditions
Staphylococcus Aureus Bacteremia
Interventions
Drug: Early Dual IV Antibiotic Therapy - MRSA
Drug: Single Agent IV Antibiotic Therapy - MRSA
Drug: Early Dual IV Antibiotic Therapy - MSSA
Drug: Single Agent IV Antibiotic Therapy - MSSA
First Posted Date
2025-08-29
Last Posted Date
2025-09-17
Lead Sponsor
West Virginia University
Target Recruit Count
300
Registration Number
NCT07148960
Locations
🇺🇸

West Virginia University, Morgantown, West Virginia, United States

Dyed vs. Undyed Polyglactin Sutures in Cutaneous Surgery

Not Applicable
Conditions
Wound Closure
Suture Materials
First Posted Date
2025-07-22
Last Posted Date
2025-07-22
Lead Sponsor
West Virginia University
Target Recruit Count
50
Registration Number
NCT07078669
Locations
🇺🇸

WVU Medicine Waynesburg Dermatology, Waynesburg, Pennsylvania, United States

Preventing Perinatal Anxiety: Testing an Internet-delivered Intervention

Not Applicable
Not yet recruiting
Conditions
Postpartum Disorder
First Posted Date
2025-07-17
Last Posted Date
2025-07-17
Lead Sponsor
West Virginia University
Target Recruit Count
100
Registration Number
NCT07071025
Locations
🇺🇸

Life Sciences Building, Morgantown, West Virginia, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 29
  • Next

News

Ryght AI Secures $3M Seed Funding and Expands Academic Partnerships to Accelerate Clinical Trial Site Selection

Ryght AI raised $3 million in seed funding led by Foothill Ventures to advance its AI-powered clinical trial platform that creates digital twins of over 100,000 research sites worldwide.

FDA Clears ZEISS INTRABEAM 700: Advanced Robotic-Assisted Platform for Intraoperative Radiotherapy

ZEISS INTRABEAM 700 has received FDA 510(k) clearance, offering robotic-assisted precision for intraoperative radiation therapy in neuro-oncology and breast cancer treatment.

WVU Study to Compare Buprenorphine Formulations for Opioid Use Disorder in Rural Setting

West Virginia University (WVU) will conduct a study comparing oral film versus injectable buprenorphine for opioid use disorder treatment in rural areas.

NIH Launches CARE for Health Network to Enhance Primary Care Research

The NIH is investing $30 million to launch the CARE for Health network, aimed at integrating clinical research with community-based primary care.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.